Group One Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84K Sell
1,300
-11,900
-90% -$839K ﹤0.01% 4881
2025
Q4
$888K Buy
13,200
+11,000
+500% +$740K ﹤0.01% 2999
2025
Q3
$161K Sell
2,200
-3,700
-63% -$246K ﹤0.01% 4904
2025
Q2
$307K Sell
5,900
-4,500
-43% -$256K ﹤0.01% 3907
2025
Q1
$664K Buy
10,400
+9,400
+940% +$546K ﹤0.01% 2818
2024
Q4
$47.8K Sell
1,000
-17,600
-95% -$902K ﹤0.01% 5086
2024
Q3
$1.06M Buy
18,600
+17,000
+1,063% +$975K ﹤0.01% 2240
2024
Q2
$83.8K Sell
1,600
-3,300
-67% -$145K ﹤0.01% 4103
2024
Q1
$199K Buy
4,900
+3,600
+277% +$135K ﹤0.01% 3566
2023
Q4
$48K Sell
1,300
-8,400
-87% -$316K ﹤0.01% 5087
2023
Q3
$371K Sell
9,700
-1,000
-9% -$41K ﹤0.01% 3219
2023
Q2
$386K Buy
10,700
+600
+6% +$20.5K ﹤0.01% 3280
2023
Q1
$386K Sell
10,100
-22,200
-69% -$1.04M ﹤0.01% 3010
2022
Q4
$1.84M Buy
32,300
+22,700
+236% +$1.16M ﹤0.01% 1897
2022
Q3
$380K Hold
9,600
﹤0.01% 3499
2022
Q2
$422K Sell
9,600
-3,300
-26% -$143K ﹤0.01% 3590
2022
Q1
$514K Sell
12,900
-4,500
-26% -$160K ﹤0.01% 3780
2021
Q4
$700K Sell
17,400
-2,800
-14% -$105K ﹤0.01% 3732
2021
Q3
$822K Sell
20,200
-4,000
-17% -$167K ﹤0.01% 3629
2021
Q2
$1.1M Sell
24,200
-2,200
-8% -$97.4K ﹤0.01% 3302
2021
Q1
$1.1M Buy
26,400
+20,000
+313% +$913K ﹤0.01% 3117
2020
Q4
$273K Buy
6,400
+2,500
+64% +$89.9K ﹤0.01% 3817
2020
Q3
$102K Sell
3,900
-100
-3% -$2.79K ﹤0.01% 4180
2020
Q2
$107K Buy
4,000
+1,000
+33% +$22.6K ﹤0.01% 3854
2020
Q1
$54K Sell
3,000
-22,100
-88% -$419K ﹤0.01% 3660
2019
Q4
$445K Sell
25,100
-3,900
-13% -$67.5K ﹤0.01% 2522
2019
Q3
$450K Sell
29,000
-900
-3% -$14.8K ﹤0.01% 2419
2019
Q2
$514K Sell
29,900
-30,800
-51% -$497K ﹤0.01% 2102
2019
Q1
$977K Buy
60,700
+5,400
+10% +$87.5K 0.01% 1424
2018
Q4
$809K Sell
55,300
-1,200
-2% -$19.1K 0.01% 1657
2018
Q3
$1.03M Buy
56,500
+9,400
+20% +$165K 0.01% 1679
2018
Q2
$795K Sell
47,100
-10,100
-18% -$191K 0.01% 1915
2018
Q1
$1.12M Sell
57,200
-82,700
-59% -$1.6M 0.01% 1436
2017
Q4
$2.83M Sell
139,900
-22,900
-14% -$421K 0.02% 977
2017
Q3
$2.83M Buy
162,800
+31,500
+24% +$427K 0.03% 841
2017
Q2
$1.68M Sell
131,300
-93,900
-42% -$1.25M 0.02% 1062
2017
Q1
$2.92M Buy
225,200
+129,800
+136% +$1.64M 0.03% 639
2016
Q4
$943K Buy
95,400
+27,500
+41% +$301K 0.01% 1348
2016
Q3
$820K Buy
67,900
+1,300
+2% +$13.3K 0.01% 1423
2016
Q2
$575K Buy
66,600
+18,100
+37% +$179K 0.01% 1632
2016
Q1
$459K Sell
48,500
-262,500
-84% -$2.47M 0.01% 1749
2015
Q4
$5.39M Sell
311,000
-43,100
-12% -$687K 0.06% 340
2015
Q3
$4.76M Buy
354,100
+67,500
+24% +$1.36M 0.07% 361
2015
Q2
$6.47M Buy
286,600
+161,100
+128% +$2.83M 0.09% 238
2015
Q1
$1.79M Sell
125,500
-169,400
-57% -$2.44M 0.03% 701
2014
Q4
$2.85M Buy
294,900
+160,000
+119% +$1.42M 0.04% 474
2014
Q3
$1.23M Sell
134,900
-9,600
-7% -$91.4K 0.02% 959
2014
Q2
$1.43M Buy
144,500
+54,300
+60% +$461K 0.02% 911
2014
Q1
$1.15M Sell
90,200
-63,200
-41% -$938K 0.02% 984
2013
Q4
$2.3M Sell
153,400
-240,500
-61% -$3.09M 0.03% 576
2013
Q3
$4.35M Buy
393,900
+176,900
+82% +$1.47M 0.08% 253
2013
Q2
$1.73M Buy
+217,000
New +$1.38M 0.04% 499

Other funds holding HALO

Group One Trading's HALO Position: Q4 2024 in Review

Group One Trading sold out of Halozyme (HALO) in Q4 2024, closing a stake of 9,855 shares — an estimated $505K sold.

Group One Trading first reported a position in HALO in Q2 2013 and held it in 22 quarters. The position peaked at $3.07M in Q4 2013. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Group One Trading reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 9,855 Halozyme shares in Q4 2024, an estimated $505K.
  • Group One Trading first reported a position in Halozyme in Q2 2013 and held it in 22 quarters.
  • Group One Trading's Halozyme position peaked at $3.07M in Q4 2013.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.